GeoVax to Showcase Innovative Vaccines and Therapies at BIO International Convention 2025
GeoVax Labs, Inc. announces its participation in the 2025 BIO International Convention, highlighting its pipeline of vaccines and immunotherapies for infectious diseases and cancer, underscoring the company's role in advancing global health solutions.
